Dr. Cheguevara Afaneh, MD, FACS is a general surgeon in New York, NY specializing in general surgery, general practice and bariatric surgery. Dr. Cheguevara Afaneh, MD, FACS is affiliated with NewYork-Presbyterian, General Surgery - Upper East Side and WEILL MEDICAL COLLEGE OF CORNELL.
520 East 70th Street Starr Pavilion, 8th Floor
New York, NY 10021
Gallbladder Removal Surgery (Cholecystectomy)
The gallbladder is a small, pear-shaped organ on the right side of the upper abdomen, underneath the liver. Its purpose is to store bile, which is used to digest fat. Occasionally, the gallbladder can develop mineral stones, called gallstones. If they are large enough, gallstones can block the ducts in the gallbladder and cause swelling and infection. Gallstones can be treated with lifestyle changes and medication, but sometimes this is not enough. In these cases, it is best to remove the gallbladder before it can cause more serious problems. The surgical removal of the gallbladder is called a cholecystectomy.
Today, most gallbladder surgeries are done laparoscopically. Four tiny incisions are made in the abdomen, and small tools are inserted through these tiny incisions to perform the surgery. Because the incisions are much smaller, recovery time is much faster with this type of surgery. Patients are usually discharged from the hospital the same day. Sometimes, open surgery is used to remove a gallbladder. In this type of surgery, a cut about six inches long is made in the upper right abdomen. After the gallbladder is removed, it is sutured or stapled closed. With open surgery, patients usually stay in the hospital for two to three days to recover before they are discharged.
Gallbladder removal, like any surgery, carries some risks, such as bleeding, infection, or the development of blood clots. Doctors will tell patients how to minimize their risk for complications. After surgery, patients are advised to avoid strenuous activity for several days. They should not soak in a bath until their sutures or staples have been removed. Patients should wash hands before touching the area around the incision. It will take a couple of days until patients feel like themselves again and a few weeks until their scar has healed and faded.
Robotic Surgery
Robotic surgery is a type of minimally invasive surgery, using a tiny opening to get inside the body instead of making a large cut. It uses small tools attached to a thin robotic arm, which is controlled by the surgeon. Robotic surgery may be referred to by the specific kind of robot that is used. The most advanced robot currently in use is called the da Vinci, and surgery using it is sometimes called da Vinci surgery.
There are many benefits to robotic surgery, both for the patient and the surgeon. Robotic surgery allows for more precise movements and increased control during very delicate surgical procedures. This makes performing surgery accurately much easier for surgeons and reduces fatigue. The smaller 'hand' of the robot can enter the body via a much smaller opening, which reduces the risk of infection and scarring and leads to a faster recovery. The robotic hands also contain tiny moveable cameras among their tools, giving surgeons a much closer view of the procedure than would be possible with traditional surgery.
Weight Loss Surgery (Bariatric Surgery)
Bariatric or weight-loss surgery is a surgical procedure performed to help significantly obese patients lose weight when more traditional methods, such as dieting and exercise, have not helped. Depending on the type, these surgeries change the gastrointestinal tract to limit how much food can be eaten and also change how food is absorbed by the body. Of the various bariatric surgeries available, the most common is gastric bypass.
By far the most common of the gastric bypass surgeries is called Roux-en-Y. During this surgery, part of the stomach and small intestine are detached from the gastrointestinal tract, in order to make the tract smaller. The surgeon divides the stomach into two parts. The working stomach, at the end of the esophagus, is now tiny - only the size of a walnut. This makes patients feel full after eating a small amount of food. Then the small intestine is also divided, and after bypassing a section of the small intestine to reduce food absorption, the intestine is attached to the small stomach pouch. The patient now has a working stomach and intestine like before, only much smaller.
Because gastric bypass is used to treat extreme obesity, it can reduce the risk of some of the problems associated with obesity. Gastric bypass can help treat or reduce the risk for such conditions as heart disease, high blood pressure, sleep apnea, and type 2 diabetes. However, it is a major surgery and also carries risks itself. Any surgery can lead to infection, bleeding, or blood clots, and weight loss surgery in particular carries risks of leaks in the gastrointestinal system, malnutrition, bowel obstructions, and vomiting.
Typically patients are considered candidates for gastric bypass surgery if they have a BMI greater than 40, or sometimes if they have a BMI between 35 and 40 but are suffering from obesity-related illnesses such as diabetes. The outlook is generally good, with most patients losing between 50-75% of their excess weight in 1-2 years. However, patients must follow strict diet guidelines so that the stomach can heal, starting with no food at all, then followed by a liquid diet for some time. For many severely obese patients who have tried strict diets before without success, gastric bypass surgery is the tool that allows them to finally achieve their weight loss and health goals.
Volume of procedures performed by Dr. Cheguevara Afaneh, MD, FACS for Medicare patients.
The highest averages for the top procedures that Dr. Cheguevara Afaneh, MD, FACS treated as a general surgeon in New York, NY were minimally invasive procedures, gastrointestinal procedures, hospital care and inpatient care.
| 17 | |
| 12 | |
| 18 | |
| 43 | |
| 203 | |
| 69 | |
| 44 | |
| 44 | |
| 69 | |
| 15 | |
| 43 |
Information about Medicare patients treated by Dr. Cheguevara Afaneh, MD, FACS.
| 80 | |
| 79 |
| 27 | |
| 5 | |
| 93 | |
| 21 | |
| 6 |
| 30 | |
| 12 | |
| 39 | |
| 67 |
The highest averages of the most common conditions of Medicare patients that Dr. Cheguevara Afaneh, MD, FACS treated were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.
| 52 | |
| 44 | |
| 4 | |
| 38 | |
| 18 | |
| 38 | |
| 9 | |
| 5 | |
| 17 | |
| 7 | |
| 26 | |
| 7 | |
| 8 | |
| 7 |
He is certified by the Surgery and has a state license in New York.
Board Certification: Surgery
Licensed In: New York
Dr. Cheguevara Afaneh, MD, FACS is associated with these hospitals and organizations:
Dr. Cheguevara Afaneh, MD, FACS appears to accept the following insurance providers: GHI, VNSNY CHOICE, Health Insurance Plan of NY (HIP), Oxford Health Plans, Empire Blue Cross/Blue Shield, Aetna - NYP, AETNA, United Healthcare, Health Insurance Plan of New York (HIP), Group Health Incorporated (GHI), Aetna, Empire BlueCross BlueShield, United Healthcare and Oxford Health Plans.
According to our sources, Dr. Cheguevara Afaneh, MD, FACS accepts the following insurance providers:
Dr. Cheguevara Afaneh, MD, FACS does not have any reviews yet, be the first to leave a review of Dr. Cheguevara Afaneh, MD, FACS here: Leave a Review
These charts describe general payments received by Dr. Cheguevara Afaneh, MD, FACS. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$999,729
Da Vinci Surgical System $950,129 |
DA VINCI SP $49,600 |
|||||
|
$374,500
SYNECOR Biomaterial $221,063 |
GORE SYNECOR Biomaterial $47,724 |
BIO-A Tissue Reinforcement $33,262 |
GORE BIO-A Tissue Reinforcement $21,506 |
GORE ENFORM Preperitoneal Biomaterial $21,039 |
Other $29,906 |
|
|
$3,297
LINX Reflux Management System $772 |
$2,525 |
|||||
|
$1,050
Covidien $750 |
Instruments and Ligation $300 |
|||||
|
$929
Progel $294 |
SURGICAL $121 |
DAV-Phasix $14 |
$500 |
|||
|
$2,256
Senhance $600 |
SPYGLASS $316 |
Orbera $284 |
STENTS $178 |
LINX $127 |
Other $750 |
| $700,850 | |
| $277,404 | |
| $159,678 | |
| $145,700 | |
| $56,832 | |
| $41,297 |
Dr. Cheguevara Afaneh, MD, FACS has received 2 research payments totaling $16,825.
Dr. Cheguevara Afaneh is a specialist in general practice, general surgery, and bariatric surgery in New York, NY. He is professionally affiliated with NewYork-Presbyterian. Yext reports that Dr. Afaneh is accepting new patients at his office in New York, NY.
